COVICARE

While COVID-19 symptoms may pass quickly for some people, millions of others face lingering symptoms called long COVID, PASC (Post-acute sequelae of SARS-CoV-2), or post-COVID syndrome. Long COVID can affect anyone – children and adults, otherwise healthy people and those with other health cond

Ivermectin, the anti-parasitic drug, has been widely used in India and many other countries as an off-label medication to treat COVID-19 mild and moderate COVID-19 patients, despite limited evidence of its efficacy. The European Medicines Agency (EMA), which regulates drugs in the EU, on March 2

Washington: A peer-reviewed research has claimed that global ivermectin use can end the Covid-19 pandemic, as the medicine significantly reduces the risk of contracting the deadly respiratory disease when used regularly. The common antiparasitic ivermectin is being shown as a miracle cure for Cov

In a few short months the SARS-CoV-2 coronavirus has spread throughout the world. The virus can infect the respiratory (breathing) system, causing fever and a continuous cough, and can develop into pneumonia. There is currently no vaccine against the virus or approved specific treatment for COVID-19